Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
28M
-
Number of holders
-
115
-
Total 13F shares, excl. options
-
31M
-
Shares change
-
+1.52M
-
Total reported value, excl. options
-
$630M
-
Value change
-
+$27.6M
-
Put/Call ratio
-
0.05
-
Number of buys
-
53
-
Number of sells
-
-58
-
Price
-
$20.30
Significant Holders of ANAPTYSBIO, INC - Common Stock, par value $0.001 per share (ANAB) as of Q2 2022
139 filings reported holding ANAB - ANAPTYSBIO, INC - Common Stock, par value $0.001 per share as of Q2 2022.
ANAPTYSBIO, INC - Common Stock, par value $0.001 per share (ANAB) has 115 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31M shares
.
Largest 10 shareholders include EcoR1 Capital, LLC (7.52M shares), TANG CAPITAL MANAGEMENT LLC (2.63M shares), FEDERATED HERMES, INC. (2.3M shares), BlackRock Inc. (1.77M shares), VANGUARD GROUP INC (1.73M shares), BOXER CAPITAL, LLC (1.3M shares), STATE STREET CORP (1.16M shares), DIMENSIONAL FUND ADVISORS LP (923K shares), Woodline Partners LP (921K shares), and Frazier Life Sciences Management, L.P. (900K shares).
This table shows the top 115 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.